TEE
ENZ

Tibra Equities Europe’s Enzo Biochem, Inc. ENZ Stock Holding History

Tibra Equities Europe’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-111,000
Closed -$352K – 206
2021
Q2 		$352K Buy
+111,000
New +$349K 0.11% 55

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tibra Equities Europe's ENZ Position: Q3 2021 in Review

Tibra Equities Europe sold out of Enzo Biochem, Inc. (ENZ) in Q3 2021, closing a stake of 111,000 shares — an estimated $352K sold.

Tibra Equities Europe first reported a position in ENZ in Q2 2021 and held it in 1 quarter. The position peaked at $352K in Q2 2021. 65 funds tracked by Wall St. Rank hold ENZ as of Q3 2021.

  • Tibra Equities Europe reported no remaining Enzo Biochem, Inc. position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 111,000 Enzo Biochem, Inc. shares in Q3 2021, an estimated $352K.
  • Tibra Equities Europe first reported a position in Enzo Biochem, Inc. in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Enzo Biochem, Inc. position peaked at $352K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.